ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000261251.1	Avagacestat	Bladder urothelial carcinoma	0.027561562	Resistant
ENSG00000261251.1	Avagacestat	Head and neck squamous cell carcinoma	0.005293158	Resistant